g(m3)-ganglioside and Head-and-Neck-Neoplasms

g(m3)-ganglioside has been researched along with Head-and-Neck-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for g(m3)-ganglioside and Head-and-Neck-Neoplasms

ArticleYear
Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 06-01, Volume: 24, Issue:11

    Topics: Animals; Cell Line, Transformed; Cell Line, Tumor; Fanconi Anemia Complementation Group Proteins; G(M3) Ganglioside; Glycosphingolipids; Head and Neck Neoplasms; Humans; Keratinocytes; Lipid Metabolism; Lipidomics; Metabolic Networks and Pathways; Metabolomics; Mice

2018
Tumor size-dependent elevations of serum gangliosides in patients with head and neck carcinomas.
    Biochemistry international, 1989, Volume: 18, Issue:4

    Serum gangliosides were studied in 100 patients with benign or tumoral head and neck lesions. Whereas very few changes over the normal level were noticed in benign cases, 78% of patients with head and neck carcinomas had a significant elevation of serum gangliosides, mostly accounted for by GM3 and GD3. Such an increase was correlated with the observed tumor size, and the level of serum gangliosides returned to normal within one month after surgery. Follow-up of patients showed that further elevations of serum gangliosides were associated with relapses.

    Topics: Biomarkers, Tumor; G(M3) Ganglioside; Gangliosides; Head and Neck Neoplasms; Humans; N-Acetylneuraminic Acid; Sialic Acids

1989